Celltrion stock

South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...

Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...

South Korea’s biopharmaceutical company Celltrion Inc. announced on Wednesday that it signed a joint research agreement with domestic startup ...

The Hongkong and Shanghai Banking Corporation Ltd. (HSBC) and BNP Paribas CIB have been reported to South Korean public prosecutors in violation of ...

National Pension Service (NPS) of South Korea posted an 8.66% investment return from January to September of this year with assets under management ...

Celltrion Healthcare Co. announced on Thursday that its autoimmune disease treatment Zymfentra (the US product name for Remsima SC) is set to be lau...

Korea Investment Corp. (KIC) posted a 7.12% return on total asset investments in the first eight months of this year, recouping about 40% of last ye...

South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...

South Korea’s video game team T1 led by local hero and professional player Lee “Faker” Sang-hyeok won the 2023 League of Legends W...

South Korea's Celltrion Healthcare Co. announced on Friday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for the B...

South Korea’s LG Group and Seoul-based Qraft Technologies Inc. have jointly launched an exchange-traded fund (ETF) that selects holdings relat...

South Korean pharmaceutical giant Celltrion Inc. logged record quarterly earnings on the strong performance of its key biosimilar products while exp...

South Korea has temporarily suspended short selling partly to prevent illegal, naked short selling, a decision buoying stocks heavily targeted by sh...

SK Innovation Co., South Korea’s top energy company, said its electric vehicle (EV) battery subsidiary aims to turn to the black in the fourth...

South Korea’s biosimilar drugmaker Celltrion group on Monday moved one step closer to the planned combination of its three major affiliates wi...

South Korea's Celltrion Inc. announced on Monday it received a new drug approval for an autoimmune disease treatment Remsima SC (active ingredient i...

Shares of HMM Co., South Korea’s No. 1 container line, are likely to fall as its main creditors exchanged perpetual convertible bonds (CBs) an...

South Korea's Celltrion Healthcare Co. announced on Wednesday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for ho...

South Korea's Celltrion Healthcare Co. has inked a deal with the US specialty pharmacy chain CarePartners Pharmacy to supply its autoimmune disease ...

South Korean drug giant Celltrion Group has received a positive recommendation from Institutional Shareholder Services (ISS), a global leading proxy...

Celltrion Pharm Inc. announced on Wednesday that its pre-filled syringe (PFS) production facility in Cheongju, North Chungcheong Province has obtain...

The South Korean financial markets were roiled by a fresh taper tantrum after the US Federal Reserve chair signaled further tightening last week, tr...

South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it has secured approval from the Japanese Ministry of Health, Labou...

Celltrion Inc., a South Korean biopharmaceutical giant, said Monday it will provide biosimilars worth 423.6 billion won ($323.6 million), its larges...

Shinyoung Asset Management Co. has joined hands with Baillie Gifford & Co., a UK investment management firm, to launch a long-term growth stock ...

South Korea's Celltrion Healthcare Co. announced on Monday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatm...

The use of data and computing is a new paradigm in the biopharmaceutical industry, reducing the new drug development time and cost, Celltrion Inc. C...

South Korean biopharmaceutical firm Celltrion Inc. announced on Tuesday that it plans to enlarge its finished pharmaceuticals manufacturing facility...

Shinhan Investment & Securities announced on Thursday that its local subsidiary in Indonesia has organized the listing of private hospital RSCH ...

National Pension Service (NPS) of South Korea achieved a 9.1% return on investment during the first half of this year, with assets under management ...